Summary
A former healthcare company executive has been sentenced to five years in federal prison after admitting involvement in a massive $212 million investment fraud scheme linked to a publicly traded healthcare services company. Federal prosecutors said the fraud misled investors, financial institutions, and private firms by using fake financial records, false revenue claims, and fabricated business information.
The fraud scheme lasted from 2015 to 2017 and involved efforts to artificially increase the company’s value before a major financial transaction. Authorities stated that victims believed the company was worth more than $300 million because of false information presented to investors and lenders.
Major Points From the Investigation
- Investors were allegedly shown false financial data.
- Fake customers and revenue streams were reportedly created.
- Bank statements were altered to hide misuse of funds.
- Some subsidiary companies reportedly did not exist.
- Authorities said the fraud caused major financial losses.
- The healthcare company later filed for bankruptcy in 2018.
How the $212 Million Investment Fraud Was Carried Out
According to federal authorities, the fraud was connected to a healthcare services company that traded publicly on the London Stock Exchange’s Alternative Investment Market. The company was involved in a deal to become privately owned again.
Siupo Ernest Mo charged in alleged multi-million dollar loan fraud scheme
To finance that deal, a private investment firm reportedly invested around $82.5 million. A group of financial institutions also contributed about $130 million. Together, the funding crossed $212 million.
Investigators said the company’s leadership and associates created a false picture of the business to attract money from investors and lenders. Authorities stated that financial records were manipulated to make the healthcare company appear far more profitable than it really was.
Federal prosecutors explained that the group claimed the company was buying profitable operating businesses. However, investigators later discovered that some of those businesses either barely operated or did not exist at all.
Authorities also alleged that money raised from investors was not used for the business purposes described to investors. Instead, funds were reportedly moved through bank accounts controlled by the conspirators.
Investigators stated that false customer accounts were created to make the incoming money appear legitimate. Fake revenue streams were allegedly recorded in company documents to convince investors that the healthcare business was generating strong earnings.
Court documents described how altered bank statements and fabricated financial records were used during the fraud scheme. Prosecutors said these fake records created the impression that the healthcare company had stable revenue and expanding operations.
Former NFL player sentenced to over 16 years in prison for $197m medicare fraud — DOJ
Reported Fraud Techniques Used in the Scheme
- Fabricating revenue records
- Creating fake customers
- Altering bank statements
- Misrepresenting subsidiary companies
- Moving investor funds through controlled accounts
- Providing false financial information to investors
Federal investigators uncovered the scheme in 2017 after several individuals connected to the company resigned or were removed from their positions.
Company Collapse and Federal Sentencing
After the fraud scheme became public, the healthcare company experienced severe financial problems. In March 2018, the company and several affiliated businesses filed for bankruptcy.
Court filings linked the financial collapse directly to the fraud allegations. Authorities stated that the business had been operating with false financial information for years, leaving investors and lenders exposed to major losses.
Bradley Heppner found guilty in federal fraud case involving GWG Holdings
The former executive pleaded guilty in federal court to conspiracy to commit securities fraud. The sentencing included five years in prison, three years of supervised release after imprisonment, and more than $125 million in restitution payments to victims.
Federal authorities said the case involved extensive financial deception and required assistance from forensic accounting specialists during the investigation. Investigators reviewed bank records, financial statements, business transactions, and company documents as part of the probe.
Financial Impact of the Case
- Total financing tied to the deal exceeded $212 million.
- The company’s reported valuation surpassed $300 million.
- Victims were allegedly misled using false financial statements.
- Multiple financial institutions were affected.
- The company eventually entered bankruptcy proceedings.